Evolent Health vs Radnet
Evolent Health and Radnet are similar in size: $1.88bn and $2.04bn of revenue in their latest fiscal years. Radnet grew faster (11.5% against -26.6%). Radnet kept more of each dollar of sales as profit: a net margin of -0.9% against -28.5%.
| Latest fiscal year | Evolent HealthEVH, 2025 | RadnetRDNT, 2025 |
|---|---|---|
| Revenue | $1.88bn | $2.04bn |
| Revenue growth | -26.6% | 11.5% |
| Net income | −$535m | −$18.7m |
| Operating margin | — | 3.0% |
| Net margin | -28.5% | -0.9% |
| Return on equity | -75.5% | -1.9% |
| Free cash flow | $38.8m | $85.6m |
| Cash | $152m | $767m |
| Total debt | $971m | $1.14bn |
| Debt to equity | — | 104.7% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $40.0m | — |
| Employees | 4,200 | — |
| Market value | $489m | $5.80bn |
| Price vs our value range | — | Above our value range |
| Moat score | 23 (Weak) | 26 (Weak) |
| Insider trades, 12 months | 1 buys, 1 sales | 0 buys, 15 sales |